Literature DB >> 444264

Distribution and inhibition characteristics of human brain monoamine oxidase.

F Owen, A J Cross, R Lofthouse, V Glover.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 444264     DOI： 10.1016/0006-2952(79)90307-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Monoamine oxidase activity in single nerve cell bodies from substantia nigra of rat and man.

Authors:  R Pavlin
Journal:  Experientia       Date:  1988-08-15

2.  The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.

Authors:  A M O'Carroll; C J Fowler; J P Phillips; I Tobbia; K F Tipton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

3.  Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.

Authors:  N A Garrick; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

5.  Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.

Authors:  M Strolin Benedetti; A Eschalier; A Lesage; G Dordain; V Rovei; E Zarifian; P Dostert
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Monoamine oxidase activities in human brain microvessels.

Authors:  D H Haenick; R K Ladman; J Weiss; D H Boehme; W H Vogel
Journal:  Experientia       Date:  1981-07-15

7.  Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.

Authors:  Junchao Tong; Jeffrey H Meyer; Yoshiaki Furukawa; Isabelle Boileau; Li-Jan Chang; Alan A Wilson; Sylvain Houle; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-13       Impact factor: 6.200

8.  beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.

Authors:  V Glover; J Liebowitz; I Armando; M Sandler
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.